These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7591417)

  • 21. Comparative study of the efficacy of oral ketoconazole with intra-lesional meglumine antimoniate (Glucantime) for the treatment of cutaneous leishmaniasis.
    Salmanpour R; Handjani F; Nouhpisheh MK
    J Dermatolog Treat; 2001 Sep; 12(3):159-62. PubMed ID: 12243707
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative study between terbinafine 1% emulsion-gel versus ketoconazole 2% cream in tinea cruris and tinea corporis.
    Bonifaz A; Saúl A
    Eur J Dermatol; 2000 Mar; 10(2):107-9. PubMed ID: 10694308
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Uncommon clinical presentations of cutaneous leishmaniasis in Sudan.
    Elamin EM; Guerbouj S; Musa AM; Guizani I; Khalil EA; Mukhtar MM; Elkadaro AM; Mohamed HS; Ibrahim ME; Abdel Hamid MM; El Azhari M; El Hassan AM
    Trans R Soc Trop Med Hyg; 2005 Nov; 99(11):803-8. PubMed ID: 16099005
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Can pityriasis versicolor be treated with 2% ketoconazole foam?
    Cantrell WC; Elewksi BE
    J Drugs Dermatol; 2014 Jul; 13(7):855-9. PubMed ID: 25007370
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of topical ketoconazole in cutaneous leishmaniasis.
    Abahusein A; Larbi EB; al-Khawajah A; al-Gindan Y; Jain S
    East Afr Med J; 1992 Jan; 69(1):14-7. PubMed ID: 1628541
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical features and diagnosis of 42 travellers with cutaneous leishmaniasis.
    Scarisbrick JJ; Chiodini PL; Watson J; Moody A; Armstrong M; Lockwood D; Bryceson A; Vega-López F
    Travel Med Infect Dis; 2006 Jan; 4(1):14-21. PubMed ID: 16887720
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of ketoconazole in post-kala-azar dermal leishmaniasis.
    Ramesh V; Saxena U; Misra RS
    Arch Dermatol; 1992 Mar; 128(3):411-2. PubMed ID: 1550382
    [No Abstract]   [Full Text] [Related]  

  • 28. Evaluation of pentamidine for the treatment of cutaneous leishmaniasis in Colombia.
    Soto-Mancipe J; Grogl M; Berman JD
    Clin Infect Dis; 1993 Mar; 16(3):417-25. PubMed ID: 8384011
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Successful treatment of cutaneous leishmaniasis with allopurinol after failure of treatment with ketoconazole.
    Baum KF; Berens RL
    Clin Infect Dis; 1994 May; 18(5):813-5. PubMed ID: 8075279
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Evaluation of ketoconazole formulations for topical use in cutaneous leishmaniasis caused by Leishmania (Viannia)].
    Vera AM; Casadiego OA; Mantilla JC; Escobar P
    Rev Peru Med Exp Salud Publica; 2018; 35(3):476-482. PubMed ID: 30517509
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized double-blind, non-inferiority Phase II trial, comparing dapaconazole tosylate 2% cream with ketoconazole 2% cream in the treatment of Pityriasis versicolor.
    Gobbato AA; Babadópulos T; Gobbato CA; Ilha Jde O; Gagliano-Jucá T; De Nucci G
    Expert Opin Investig Drugs; 2015; 24(11):1399-407. PubMed ID: 26419668
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A therapeutic trial of oral ketoconazole in the treatment of pityriasis versicolor].
    Fenniche S; Haouet S; Ben Osman A
    Tunis Med; 1995; 73(6-7):259-62. PubMed ID: 9506175
    [No Abstract]   [Full Text] [Related]  

  • 33. Ketoconazole for the treatment of tinea versicolor.
    Goodless DR
    Int J Dermatol; 1998 Jan; 37(1):77. PubMed ID: 9522248
    [No Abstract]   [Full Text] [Related]  

  • 34. [Combination of cyclosporin and ketoconazole in immunosuppression schemes in patients with transplanted kidney].
    Treĭvish VS; Shoĭkhet IN; Ankova EV
    Klin Med (Mosk); 1998; 76(1):40-2. PubMed ID: 9532915
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Successful treatment of a case of extense verrucous chromoblastomychosis with surgical exeresis associated with the use of ketoconazole].
    Moreira Preciado M; Díaz Almeida JG; Moredo Romo E; Pérez López A; de la Torre Navarro L
    Rev Cubana Med Trop; 2005; 57(3):226-9. PubMed ID: 17969280
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Topical treatment of persistent cutaneous leishmaniasis with ethanolic lipid amphotericin B.
    Zvulunov A; Cagnano E; Frankenburg S; Barenholz Y; Vardy D
    Pediatr Infect Dis J; 2003 Jun; 22(6):567-9. PubMed ID: 12828157
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Baboon syndrome induced by ketoconazole.
    Gulec AI; Uslu E; Başkan E; Yavuzcan G; Aliagaoglu C
    Cutan Ocul Toxicol; 2014 Dec; 33(4):339-41. PubMed ID: 24641119
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Ketoconazole foaming gel in tinea versicolor (report of 60 cases)].
    el Euch D; Riahi I; Mokni M; Ben Osman A; Mezlini S; Abidi H
    Tunis Med; 1999 Jan; 77(1):38-40. PubMed ID: 10333696
    [No Abstract]   [Full Text] [Related]  

  • 39. Disseminated Cutaneous Leishmaniasis, a Patient with 178 Lesions Cured with Fluconazole.
    Sousa AQ; Lima Pompeu MM; Pearson RD
    Am J Trop Med Hyg; 2016 Jan; 94(1):1-2. PubMed ID: 26740094
    [No Abstract]   [Full Text] [Related]  

  • 40. Ketoconazole treatment of chronic mucocutaneous candidiasis.
    Montagnani A; Negosanti M; Patrizi A
    Drugs Exp Clin Res; 1986; 12(5):409-12. PubMed ID: 3522160
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.